Dupixent Study for Alternate Administration

NCT06750471 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

FED

Sponsor class

Conditions

Nasal Polyps
Sinusitis
Chronic Disease

Interventions

BIOLOGICAL: Dupilumab

Sponsor

Madigan Army Medical Center

Collaborators

[object Object]
[object Object]
[object Object]